According to the Zhitong Finance APP, Guangzhou Wondfo Biotech (300482.SZ) released the third quarter report for 2024. The company's revenue for the first three quarters was 2.181 billion yuan, an 8.83% year-on-year increase. The net income attributable to shareholders of the listed company was 0.436 billion yuan, a 9.04% year-on-year increase. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.388 billion yuan, a 14.88% year-on-year increase. The basic earnings per share was 0.94 yuan.